These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2. Tijono SM; Palmer BD; Tomek P; Flanagan JU; Henare K; Gamage S; Braun L; Ching LM Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145311 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological evaluation of urea substituted 1,2,5-oxadiazole-3-carboximidamides as novel indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors. Ye K; Wang K; Wang T; Tang H; Wang L; Zhang W; Jiang S; Zhang X; Zhang K Eur J Med Chem; 2023 Mar; 250():115217. PubMed ID: 36842272 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of oxindoles as promising inhibitors of the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1. Paul S; Roy A; Deka SJ; Panda S; Srivastava GN; Trivedi V; Manna D Medchemcomm; 2017 Aug; 8(8):1640-1654. PubMed ID: 30108875 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of isoxazolo[5,4-d]pyrimidin-4(5H)-one derivatives as antithrombotic agents. Yang J; Su G; Ren Y; Chen Y Bioorg Med Chem Lett; 2015 Feb; 25(3):492-5. PubMed ID: 25559742 [TBL] [Abstract][Full Text] [Related]
6. Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties. Qian S; He T; Wang W; He Y; Zhang M; Yang L; Li G; Wang Z Bioorg Med Chem; 2016 Dec; 24(23):6194-6205. PubMed ID: 27769672 [TBL] [Abstract][Full Text] [Related]
7. Discovery of a Novel Scaffold as an Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Based on the Pyrrolopiperazinone Alkaloid, Longamide B. Shiokawa Z; Kashiwabara E; Yoshidome D; Fukase K; Inuki S; Fujimoto Y ChemMedChem; 2016 Dec; 11(24):2682-2689. PubMed ID: 27863031 [TBL] [Abstract][Full Text] [Related]
8. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening. Sari S; Tomek P; Leung E; Reynisson J Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388 [TBL] [Abstract][Full Text] [Related]
11. 1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2). Röhrig UF; Majjigapu SR; Caldelari D; Dilek N; Reichenbach P; Ascencao K; Irving M; Coukos G; Vogel P; Zoete V; Michielin O Bioorg Med Chem Lett; 2016 Sep; 26(17):4330-3. PubMed ID: 27469130 [TBL] [Abstract][Full Text] [Related]
13. Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents. Wen H; Liu Y; Wang S; Wang T; Zhang G; Chen X; Li Y; Cui H; Lai F; Sheng L Molecules; 2019 Jun; 24(11):. PubMed ID: 31195673 [TBL] [Abstract][Full Text] [Related]
14. Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. Röhrig UF; Majjigapu SR; Vogel P; Zoete V; Michielin O J Med Chem; 2015 Dec; 58(24):9421-37. PubMed ID: 25970480 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors. Song X; Sun P; Wang J; Guo W; Wang Y; Meng LH; Liu H Eur J Med Chem; 2020 Mar; 189():112059. PubMed ID: 31981851 [TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of L- and D-5-[ Tang T; Gill HS; Ogasawara A; Tinianow JN; Vanderbilt AN; Williams SP; Hatzivassiliou G; White S; Sandoval W; DeMent K; Wong M; Marik J Nucl Med Biol; 2017 Aug; 51():10-17. PubMed ID: 28511073 [TBL] [Abstract][Full Text] [Related]
17. Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660 [TBL] [Abstract][Full Text] [Related]
18. Fused Heterocyclic Compounds as Potent Indoleamine-2,3-dioxygenase 1 Inhibitors. Panda S; Roy A; Deka SJ; Trivedi V; Manna D ACS Med Chem Lett; 2016 Dec; 7(12):1167-1172. PubMed ID: 27994758 [TBL] [Abstract][Full Text] [Related]
19. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors. Gao D; Li Y Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475 [TBL] [Abstract][Full Text] [Related]
20. Discovery of 5-(pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Kong KM; Zhang JW; Liu BZ; Meng GR; Zhang Q Bioorg Med Chem Lett; 2020 Feb; 30(4):126901. PubMed ID: 31882299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]